Equities

Prim SA

Prim SA

Actions
  • Price (EUR)10.15
  • Today's Change-0.05 / -0.49%
  • Shares traded1.65k
  • 1 Year change-8.97%
  • Beta0.5130
Data delayed at least 15 minutes, as of May 31 2024 16:35 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Prim SA is a Spain-based company principally engaged in the provision of hospital supplies. The Company’s products portfolio comprises implantable orthopedic products, silicone foot products, abduction splints, mastectomy lingerie, prosthetic components, as well as articulated electric beds and various types of accessories for geriatric centers. Through its subsidiary Inmobiliaria Catharsis SA, the Company is also active in the Real State sector. Prim SA is a parent of Grupo Prim, a group which comprises such a number of controlled entities as Enraf Nonius Iberica SA, Establecimientos Ortopedicos Prim SA, and Luga Suministros Medicos SL, among others.

  • Revenue in EUR (TTM)216.51m
  • Net income in EUR12.67m
  • Incorporated--
  • Employees900.00
  • Location
    Prim SACalle Fnumero 15., Polig. Industrial numero 1MOSTOLES 28938SpainESP
  • Phone+34 913342400
  • Fax+34 913342494
  • Websitehttps://www.prim.es/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Mercator Medical SA109.83m-4.61m114.68m961.00--0.5213--1.04-1.03-1.0356.7388.230.4582.637.06488,099.90-2.2324.69-2.3929.072.4136.99-4.8722.785.57--0.0063---13.542.2189.62---1.93--
Optomed Oyj14.95m-4.37m131.81m114.00--6.72--8.82-0.2575-0.25750.88721.080.51991.703.94131,131.60-15.21-12.95-18.59-15.9066.7665.69-29.25-27.841.72-12.960.1894--3.003.4718.84--7.26--
Amplitude Surgical SA104.05m43.23m140.22m416.003.241.482.561.350.90020.90022.171.970.39550.56528.83244,244.1016.21-0.365819.44-0.426779.4178.3040.98-1.081.210.41630.5395--14.44-0.0271993.58--7.11--
C Rad AB40.14m4.23m140.38m89.0034.095.6527.873.501.431.4313.578.611.204.903.055,266,839.0012.695.0917.967.0245.1443.1210.614.862.43--0.00580.0040.9217.44375.0510.8933.69--
Pulsion Medical Systems SE31.67m5.41m143.01m71.0026.575.1821.024.520.65490.65493.843.360.97111.773.88446,048.4016.5819.8221.2429.7263.6650.4217.0721.571.7715.740.00--20.697.87-399.21----0.00
ADDvise Group AB (publ)129.29m9.71m145.87m620.0023.873.347.431.130.58640.58647.844.200.55066.735.522,365,224.004.143.725.174.7747.6348.957.515.891.092.990.66080.940544.3038.6227.62--30.35--
Creo Medical Group PLC36.20m-25.50m155.05m287.00--2.20--4.28-0.0709-0.07090.09840.16550.40541.784.01107,317.10-28.56-26.07-34.84-30.9449.6847.58-70.45-118.243.01--0.1219--13.36--19.44------
Stille AB31.73m3.12m158.22m142.0033.492.8033.864.996.006.0060.2071.840.53641.777.183,416,557.005.277.036.358.1946.7643.939.829.850.98797.170.0021.9819.7016.78-2.485.3423.62--
Bastide Le Confort Medical SA523.32m6.32m158.82m3.55k29.591.961.930.30350.72990.77265.5711.020.79555.446.90147,580.701.842.492.663.5250.5448.822.313.050.8111.920.8391--8.4811.9411.2417.556.98--
Prim SA216.51m12.67m175.48m900.0013.831.397.730.81050.7450.74512.737.401.121.994.10240,567.406.586.689.248.9037.9338.115.856.431.22--0.1681--9.7710.0051.02-2.1412.86--
Onward Medical NV0.00-36.18m189.07m99.00--9.19-----1.20-1.200.000.5940.00----0.00-60.19-55.70-68.71-61.60-------79,513.95---58.040.4848---34.62---10.40--32.59--
Bactiguard Holding AB19.34m-11.05m192.00m191.00--7.20--9.93-3.60-3.606.309.800.30354.286.001,017,544.00-17.35-7.56-19.82-8.8129.8747.91-57.15-26.281.64-11.900.4129---11.966.46-161.71--8.43--
Tristel Plc46.41m7.09m234.63m213.0033.436.4023.335.060.12560.12560.82190.65670.9921.516.26185,394.4015.178.8617.1010.2482.5980.6315.2910.633.93411.730.1605109.9915.7010.14351.986.409.8818.05
Sedana Medical AB (publ)14.45m-2.00m234.96m83.00--2.7139,442.6216.26-0.2299-0.22991.669.950.15641.248.102,087,443.00-2.17-5.77-2.28-6.0870.5064.06-13.85-36.137.38--0.0043--25.2321.5918.90--42.12--
Data as of May 31 2024. Currency figures normalised to Prim SA's reporting currency: Euro EUR

Institutional shareholders

13.49%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 27 Apr 20231.70m9.99%
KBC Asset Management NVas of 31 Dec 2023157.28k0.92%
Independance Et Expansion AM SARLas of 30 Jun 2023154.31k0.91%
Santander Private Banking Gestion SA SGIICas of 31 Dec 202369.88k0.41%
Magallanes Value Investors SA SGIICas of 31 Dec 202365.21k0.38%
Dimensional Fund Advisors LPas of 09 May 202456.54k0.33%
March Asset Management SGIIC SAUas of 30 Jun 202333.38k0.20%
GVC Gaesco Gesti�n SGIIC SAas of 31 Mar 202421.81k0.13%
HOROS Asset Management SGIIC SAas of 31 Mar 202419.78k0.12%
Kontor St�wer Asset Management GmbHas of 30 Apr 202417.50k0.10%
More ▼
Data from 30 Jun 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.